Baby with a novel mutation in blood (NF-E2) is the first in the world to undergo a successful bone marrow transplant at Indraprastha Apollo Hospitals, Delhi.

Doctors at Indraprastha Apollo Hospitals, New Delhi, successfully performed a bone marrow transplant on a 17-month-old Filipino baby, for what can be called as world’s first ever bone marrow transplant for a novel mutation in the blood (NF-E2). As a first of its kind case to have ever been reported in the world (first published in British Journal of Hematology), the doctors at Dubai were not fully equipped to conduct a Bone Marrow Transplant for such a condition. Hence, they referred him to India to Dr Gaurav Kharya, Clinical Lead, Centre for Bone Marrow Transplant and Cellular Therapy & Senior Consultant, Pediatric Hematology, Oncology and Immunology, Indraprastha Apollo Hospitals, New Delhi. Dr Atish Bakane, Associate Consultant, Centre for Pediatric Hematology Oncology, BMT and Cellular Therapies at Indraprastha Apollo Hospitals said, “This was a challenging case for us because we had never dealt with this novel mutation. Different blood mutations react to chemotherapy drugs in a different manner, hence we closely monitored this procedure and fortunately we were able to save the baby.”

Read more about how the rare novel mutation in blood (NF-E2) was treated.